Andy Chen

Stock Analyst at Wolfe Research

(2.73)
# 2,659
Out of 4,893 analysts
39
Total ratings
40.74%
Success rate
0.07%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andy Chen

Verona Pharma
Jul 1, 2025
Initiates: Outperform
Price Target: $170
Current: $104.85
Upside: +62.14%
BridgeBio Pharma
Jun 17, 2025
Initiates: Outperform
Price Target: $49
Current: $46.27
Upside: +5.90%
Sarepta Therapeutics
Jun 17, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $19.07
Upside: -
Avidity Biosciences
Jun 17, 2025
Initiates: Outperform
Price Target: $55
Current: $31.47
Upside: +74.77%
Blueprint Medicines
Jun 3, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $129.33
Upside: -
MoonLake Immunotherapeutics
May 19, 2025
Upgrades: Outperform
Price Target: $61
Current: $48.88
Upside: +24.80%
Intellia Therapeutics
Apr 21, 2025
Upgrades: Outperform
Price Target: $21
Current: $12.16
Upside: +72.70%
AnaptysBio
Feb 4, 2025
Initiates: Outperform
Price Target: n/a
Current: $26.06
Upside: -
Crinetics Pharmaceuticals
Feb 4, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $31.97
Upside: -
89bio
Feb 4, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.77
Upside: -
Initiates: Outperform
Price Target: $20
Current: $14.08
Upside: +42.05%
Initiates: Outperform
Price Target: $49
Current: $24.35
Upside: +101.23%
Initiates: Outperform
Price Target: $19
Current: $12.07
Upside: +57.42%
Downgrades: Peer Perform
Price Target: n/a
Current: $17.50
Upside: -
Upgrades: Outperform
Price Target: $697
Current: $563.31
Upside: +23.73%
Downgrades: Underperform
Price Target: n/a
Current: $322.58
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $70.34
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $22.68
Upside: -
Upgrades: Outperform
Price Target: $65
Current: $45.21
Upside: +43.77%
Initiates: Outperform
Price Target: n/a
Current: $52.00
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $314.64
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $17.12
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $8.67
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $42.38
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $59.00
Upside: -
Initiates: Outperform
Price Target: $17
Current: $11.57
Upside: +46.93%
Initiates: Outperform
Price Target: n/a
Current: $479.53
Upside: -
Initiates: Outperform
Price Target: $42
Current: $96.66
Upside: -56.55%